A Pfizer spokeswoman said in an email to CNN Business that the sale took place because Pfizer shares hit a predetermined price as part of a plan authorized by Bourla on August 19. The scientists who developed the Pfizer/BioNTech Covid-19 vaccine are a Turkish-German power couple
Full Answer
What is wrong with Pfizer stock price?
Pfizer Inc.’s ability to supply billions of doses of its Covid-19 vaccine hinges on two employees working on opposite sides of the world. From her home in Andover, Mass., Amy Genest scouts for companies that can make Pfizer’s shot. After finding a ...
Is Pfizer publicly traded?
P fizer, the world’s largest drug company, is going to try its hand at picking biotech stocks. The New York pharma giant has set aside up to $500 million that it will invest in publicly traded...
Why has Pfizer stock floundered?
Pfizer chief corporate affairs chief Sally Sussman shares lessons from how the company responded to the global pandemic. INC. TODAY'S MUST READS: New Research: Status Reports Can Make Teams Less Effective INC. TODAY'S MUST READS: How to Stay Innovative ...
Will Pfizer stock go up?
Pfizer still has a slight edge with its approval as it is for ages 16 and up compared to Moderna, which is 18 and up. Approval also provides a measure of protection as an EUA can always be ...
Is selling a stake good?
Selling the bulk of your stake never looks good, but especially when public confidence in your company is a matter of life or death. Author of the article:
Can planned sales create question marks?
But it all shows that planned sales can create question marks as well as remove them.
The Last 12 Months Of Insider Transactions At Pfizer
Over the last year, we can see that the biggest insider purchase was by Independent Director Ronald Blaylock for US$501k worth of shares, at about US$38.69 per share. We do like to see buying, but this purchase was made at well below the current price of US$45.68.
Does Pfizer Boast High Insider Ownership?
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that Pfizer insiders own 0.05% of the company, worth about US$127m.
So What Do The Pfizer Insider Transactions Indicate?
An insider sold stock recently, but they haven't been buying. But we take heart from prior transactions. And insider ownership remains quite considerable. So we're not too bothered by recent selling.
How much did Pfizer sell in 2020?
Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news. By Paul R. La Monica, CNN Business. Updated 12:15 PM ET, Wed November 11, 2020. New York (CNN Business) Pfizer CEO Albert Bourla filed to sell millions of dollars of his company's stock Monday -- the day the pharmaceutical giant announced positive data about its ...
How much did Bourla sell Pfizer?
Bourla sold 132,508 Pfizer ( PFE) shares at a price of $41.94, according to a filing with the Securities and Exchange Commission. That works out to proceeds of nearly $5.6 million.
Why do companies sell stock at predetermined intervals?
Many executives sell stock at predetermined intervals to diversify their portfolios. But they can delay the sales to avoid appearances of capitalizing on one-off events that can boost company's shares. Bouria told CNN's Sanjay Gupta that he learned of the trial's results Sunday, a day before they were made public.
Did the EU buy Pfizer?
EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine. The Pfizer stock sale comes just a few months after executives at Moderna ( MRNA), a biotech also working on a Covid-19 vaccine, sold shares following the release of promising trial results.
Is Pfizer more than 90% effective?
The company's shares soared after Pfizer and European drug company BioNTech said early data suggests the vaccine could be more than 90% effective. The transaction was part of a regularly scheduled plan set up by Bourla to periodically sell some of his Pfizer shares.
Is Viatris revenue stable?
Even with the company's headwinds, its revenue should be relatively stable throughout the first half of the decade and potentially grow in the second half. Viatris' bottom line should improve throughout the period as it realizes cost synergies.
Does Viatris pay dividends?
The new company doesn't pay a dividend yet. However, Viatris has committed to initiating a dividend program in its first full quarter of operations. Here's the kicker: Viatris intends to return a minimum of 25% of free cash flow to shareholders through its dividends.
Is Pfizer better than Viatris?
Pfizer will be able to deliver better growth going forward for one simple reason: It won't have older drugs such as Lyrica that are rapidly losing market share to generic alternatives weighing it down. However, Viatris will have those drugs in its lineup. Viatris also faces other headwinds.
Is Pfizer merging with Mylan?
Pfizer 's ( NYSE:PFE) long-awaited deal is finally done. Last week, the big drugmaker completed its merger of Upjohn with Mylan. The transaction created a new entity, Viatris ( NASDAQ:VTRS), that's a leader in branded and generic drugs and biosimilars.
The pharma stock is moving in the opposite direction of the overall market
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights
Key Points
Pfizer's shares fell as the overall market rose after a pullback in recent days related to omicron concerns.
What happened
Shares of Pfizer ( NYSE:PFE) were sinking 4.4% as of 11:18 a.m. ET on Tuesday. The big drugmaker didn't report any new developments. Today's decline appears to be a by-product of the overall market rising after a pullback in recent days due to concerns about the spread of the coronavirus omicron variant.
So what
The reality is that little has changed in the expectations about the impact of the omicron variant since Monday when Pfizer's shares rose while many stocks were dropping. As such, little has changed about Pfizer's prospects. Today's move is probably more noise than anything else.
Now what
Investors will definitely want to monitor how the efficacy of Pfizer's vaccine with a booster dose fares against the omicron variant. If the efficacy wanes, it could lead to new orders for the omicron-specific vaccine version that Pfizer and BioNTech are developing.
Why did Pfizer sell its shares?
A Pfizer spokeswoman said in an email to CNN Business that the sale took place because Pfizer shares hit a predetermined price as part of a plan authorized by Bourla on August 19.
Who is the CEO of Pfizer?
Pfizer CEO Albert Bourla filed to sell millions of dollars of his company's stock Monday -- the day the pharmaceutical giant announced positive data about its coronnavirus vaccine.
Where is Pfizer headquarters?
In this file photo from Jan. 31, 2011, people walk past the Pfizer logo at the drug company's world headquarters in New York. (AP/Mark Lennihan) Albert Bourla, DVM, Ph.D. Chief Executive Officer Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Feb. 26, 2019.
Why do companies sell stock at predetermined intervals?
Many executives sell stock at predetermined intervals to diversify their portfolios. But they can delay the sales to avoid appearances of capitalizing on one-off events that can boost company's shares. Bouria told CNN's Sanjay Gupta that he learned of the trial's results Sunday, a day before they were made public.
